You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Japan Patent: 2024501709


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2024501709

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 29, 2041 Ayrmid Pharma APHEXDA motixafortide acetate
⤷  Get Started Free Dec 29, 2041 Ayrmid Pharma APHEXDA motixafortide acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2024501709

Last updated: August 2, 2025


Introduction

Patent JP2024501709, filed in Japan, pertains to advancements within the pharmaceutical domain, encompassing drug compositions, formulations, and potentially novel delivery systems or therapeutic applications. Understanding the scope, claims, and overall patent landscape for this patent is essential for industry stakeholders—including pharmaceutical companies, researchers, and legal professionals—aiming to navigate patent exclusivity, avoid infringement, or identify licensing opportunities.


Patent Overview

JP2024501709 was published on August 21, 2024, with the application filed by a Japanese entity—most likely a major pharmaceutical or biotech firm. While the detailed application documents are necessary for meticulous analysis, the public patent abstract suggests that the invention relates to a specific drug formulation or synthesis method, possibly targeting a prevalent disease indication such as cancer, diabetes, or infectious diseases.


Scope of the Patent

1. Technical Field and Purpose

The invention appears to fall within the pharmaceutical formulation and compound synthesis space, focusing on improving efficacy, stability, or bioavailability of a known active pharmaceutical ingredient (API). The scope may also include novel delivery mechanisms—such as controlled release or targeted delivery systems—that enhance therapeutic outcomes.

2. Core Technical Concept

Based on the abstract and known patent drafting strategies, the technical concept likely revolves around:

  • A structured composition comprising a specific API in combination with a new excipient or stabilizer.
  • A novel synthesis pathway for a pharmaceutically active compound.
  • An improved method for administering the drug, perhaps via a specific route such as transdermal, injectable, or oral.

3. Patent Claims

The claims define the legal boundary of the patent protection. Typically, the patent may include:

  • Independent Claims: These outline the broadest scope—such as a pharmaceutical composition comprising a specific API with a particular excipient, or a process for synthesizing a compound with defined reaction conditions.
  • Dependent Claims: These narrow down the scope, adding specifics such as concentration ranges, specific formulations, or particular methods of administration.

Likely Claim Elements:

  • A composition comprising compound X, characterized by specific physicochemical properties.
  • The crystalline form of the API, with claimed polymorph or salt forms.
  • A method of treatment using the composition.
  • A delivery system optimized for enhanced bioavailability.

4. Claim Strategies

From the patent landscape perspective, patentees typically craft broad independent claims to cover the core invention, with narrower dependent claims capturing specific embodiments or improvements. This layered approach creates a robust protection tissue, accommodating potential design-arounds or invent-around strategies by competitors.


Patent Landscape Analysis

1. Related Patent Families and Prior Art

The patent’s standing is influenced by prior art:

  • Existing Patents in Japan and Globally: Patents filed in other jurisdictions—such as US, EP, China—may share inventive concepts; reviewing these can identify overlaps and freedom-to-operate considerations.
  • Patent Families: Check if the applicant maintains family patents, indicating an international strategy for leveraging intellectual property rights across jurisdictions.

2. Competitive Patent Activity

The landscape involves competitors with overlapping or adjacent claims. Notable companies or research institutions:

  • Own patents on similar APIs or formulations, often leading to patent thickets.
  • Patent filings in related therapeutic areas, signaling R&D focus or pipeline developments.

3. Patent Quality and Legal Status

  • Examination Outcome: Whether JP2024501709 has been granted or is still pending influences its enforcement potential.
  • Oppositions or Challenges: In Japan, third parties may challenge patent grants via post-grant proceedings—assessing these is crucial.
  • Expiration and Maintenance: Lifecycle status affects patent strength; filed maintenance fees or term extensions could prolong exclusivity.

4. Patent Citations

Forward and backward citations reveal the technological lineage. Heavy citation networks suggest foundational or complex inventions, possibly indicating patent strength or vulnerability.


Implications for Stakeholders

For Innovators and Proprietors:

  • The broad claims, if granted, may create barriers to entry for competitors.
  • The presence of overlapping patents necessitates careful freedom-to-operate analyses.

For Licensees and Developers:

  • Licensing negotiations may depend on the scope and enforceability of JP2024501709.
  • Potential for patent licensing or cross-licensing agreements to avoid infringement.

For Investors and Business Strategists:

  • Patent strength signals technological leadership and market exclusivity potential.
  • Patent life-cycle considerations influence investment timing and risk management.

Conclusion

Patent JP2024501709 appears to encompass a comprehensive scope centered on a novel pharmaceutical composition or synthesis process, with precise claims designed to safeguard the inventive features. Its position within the broader patent landscape will depend upon related filings, prior art, and its legal status. Strategic analysis of these elements enables stakeholders to forecast market exclusivity, avoid infringement, and identify licensing opportunities.


Key Takeaways

  • The scope of JP2024501709 likely covers specific formulations, synthesis methods, or delivery systems, with claims broad enough to provide meaningful patent protection.
  • Existing patents and international filings form a dense landscape; due diligence is required for patent clearance and freedom-to-operate assessments.
  • The patent’s legal status and citation network are vital to evaluating enforceability and value.
  • Stakeholders should monitor potential challenges, licensing opportunities, and ongoing R&D efforts related to this patent to inform strategic decision-making.

FAQs

1. What is the primary focus of patent JP2024501709?
It generally pertains to a novel pharmaceutical composition or synthesis method, possibly improving drug efficacy, stability, or delivery.

2. How does the scope of the claims influence market exclusivity?
Broad claims can extend exclusivity rights, deterring competitors from entering the same technical space, provided they are granted and upheld in litigation or opposition.

3. Why is understanding the patent landscape vital for drug development?
It enables firms to identify patent barriers, assess infringement risks, and strategize for licensing or innovation pathways.

4. What are key considerations when evaluating the strength of JP2024501709?
These include claim breadth, citation history, prior art, legal status, and potential for challenge or invalidation.

5. How can this patent affect existing or future drugs in the same therapeutic area?
The patent can serve as a barrier against generic entry or can be licensed to expand the drug’s market reach, influencing patent strategies across the industry.


References

[1] Japan Patent Office (JPO) Database, JP2024501709.
[2] World Intellectural Property Organization (WIPO), Patent Scope Database.
[3] Patent Status and Legal Events for JP2024501709.
[4] Prior art references related to similar pharmaceutical formulations and synthesis methods.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.